Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) Gross Margin (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Gross Margin for 16 consecutive years, with 90.37% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin rose 3182.0% year-over-year to 90.37%, compared with a TTM value of 73.0% through Dec 2025, up 687.0%, and an annual FY2025 reading of 73.0%, up 472.0% over the prior year.
  • Gross Margin was 90.37% for Q4 2025 at Orthofix Medical, up from 64.75% in the prior quarter.
  • Across five years, Gross Margin topped out at 133.19% in Q4 2022 and bottomed at 57.01% in Q4 2023.
  • Average Gross Margin over 5 years is 77.61%, with a median of 73.39% recorded in 2024.
  • The sharpest move saw Gross Margin soared 4999bps in 2022, then crashed -7618bps in 2023.
  • Year by year, Gross Margin stood at 83.21% in 2021, then skyrocketed by 60bps to 133.19% in 2022, then tumbled by -57bps to 57.01% in 2023, then increased by 3bps to 58.55% in 2024, then soared by 54bps to 90.37% in 2025.
  • Business Quant data shows Gross Margin for OFIX at 90.37% in Q4 2025, 64.75% in Q3 2025, and 72.9% in Q2 2025.